Searching for a marker for Alzheimer's disease-Apo-E

Area of Science:

• Neuroscience
• Genetics
• Gerontology

Background:

• Alzheimer's disease and multinfarctual dementia are significant causes of senile dementia.
• Identifying reliable biomarkers for early diagnosis is crucial for effective management.
• The apolipoprotein E (Apo E) gene, with its various isoforms, is a candidate for such biomarkers.

Purpose of the Study:

• To investigate the association between apolipoprotein E (Apo E) gene isoforms and dementia.
• To determine if Apo E-4 can serve as a timely diagnostic marker for senile dementia, including Alzheimer's disease and vascular dementia.

Main Methods:

• DNA analysis was performed on 10 Alzheimer's disease patients and 10 multinfarctual dementia patients.
• Specific alleles (Apo E-2, Apo E-3, Apo E-4) and their phenotype combinations were identified using DNA crossbreeding and amplification.
• The prevalence of Apo E isoforms was compared between patient groups and controls.

Main Results:

• A preliminary association was observed between the Apo E-4 isoform and Alzheimer's disease, with an estimated prevalence of around 40%.
• The findings suggest a potential role for Apo E-4 in the pathogenesis or susceptibility to Alzheimer's disease.
• These results indicate a need for larger studies to confirm the association between Apo E-4 and various forms of dementia.

Conclusions:

• The Apo E-4 isoform may be associated with an increased risk or presence of Alzheimer's disease.
• Further research with a larger patient cohort is necessary to validate the association between Apo E-4 and both Alzheimer's and vascular dementia.
• Apo E genotyping could potentially contribute to the development of early diagnostic markers for senile dementia.